Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents

Clinical trial NCT04395859 · COMPLETED

Trial details

NCT number: NCT04395859
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Status: COMPLETED
Study type: OBSERVATIONAL

Age Related Macular Degeneration Diabetic Macular Edema Retinal Vein Occlusion

Start date: 2020-05-27
Primary completion: 2021-12-15
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.